Detalles de la búsqueda
1.
Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitis.
Ann Allergy Asthma Immunol
; 129(5): 618-626.e2, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35926824
2.
AR101 Oral Immunotherapy for Peanut Allergy.
N Engl J Med
; 379(21): 1991-2001, 2018 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30449234
3.
Device mechanics and evaluation of inspiratory flow rate required of the beclomethasone dipropionate breath-actuated inhaler.
Allergy Asthma Proc
; 40(3): 162-166, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31018890
4.
Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
Allergy Asthma Proc
; 40(4): 261-272, 2019 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31053180
5.
Evaluation of beclomethasone dipropionate (80 and 160 micrograms/day) delivered via a breath-actuated inhaler for persistent asthma.
Allergy Asthma Proc
; 38(6): 419-430, 2017 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28886758
6.
No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis.
Ann Allergy Asthma Immunol
; 115(2): 137-42, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26250771
7.
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.
Int Arch Allergy Immunol
; 161(4): 369-77, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23652808
8.
Once-daily treatment with beclomethasone dipropionate nasal aerosol does not affect hypothalamic-pituitary-adrenal axis function.
Ann Allergy Asthma Immunol
; 109(5): 336-41, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23062389
9.
Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis.
Allergy Asthma Proc
; 33(5): 386-96, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23026180
10.
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
J Allergy Clin Immunol Pract
; 9(5): 1879-1889.e13, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359589
11.
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
J Asthma
; 45(4): 265-72, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18446589
12.
Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
Clin Ther
; 29(8): 1579-90; discussion 1577-8, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17919541
13.
Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies.
Allergy Asthma Clin Immunol
; 13: 18, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28392807
14.
Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.
Vaccine
; 34(18): 2096-105, 2016 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26979136
15.
Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) improves health-related quality of life in adults previously receiving inhaled corticosteroids.
Adv Ther
; 21(1): 27-38, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15191155
16.
Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Ann Allergy Asthma Immunol
; 105(2): 168-73, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20674829
17.
Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
Ann Allergy Asthma Immunol
; 99(4): 358-63, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17941284
18.
Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.
Ann Allergy Asthma Immunol
; 99(6): 549-54, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18219837
19.
Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.
Allergy Asthma Proc
; 28(2): 216-25, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17479608
20.
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
Ann Allergy Asthma Immunol
; 96(6): 851-7, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16802774